Literature DB >> 26645564

SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness.

David Crottès1, Raphael Rapetti-Mauss2, Francisca Alcaraz-Perez3, Mélanie Tichet4, Giuseppina Gariano5, Sonia Martial2, Hélène Guizouarn2, Bernard Pellissier2, Agnès Loubat2, Alexandra Popa6, Agnès Paquet6, Marco Presta5, Sophie Tartare-Deckert4, Maria Luisa Cayuela3, Patrick Martin2, Franck Borgese2, Olivier Soriani7.   

Abstract

The sigma 1 receptor (Sig1R) is a stress-activated chaperone that regulates ion channels and is associated with pathologic conditions, such as stroke, neurodegenerative diseases, and addiction. Aberrant expression levels of ion channels and Sig1R have been detected in tumors and cancer cells, such as myeloid leukemia and colorectal cancer, but the link between ion channel regulation and Sig1R overexpression during malignancy has not been established. In this study, we found that Sig1R dynamically controls the membrane expression of the human voltage-dependent K(+) channel human ether-à-go-go-related gene (hERG) in myeloid leukemia and colorectal cancer cell lines. Sig1R promoted the formation of hERG/β1-integrin signaling complexes upon extracellular matrix stimulation, triggering the activation of the PI3K/AKT pathway. Consequently, the presence of Sig1R in cancer cells increased motility and VEGF secretion. In vivo, Sig1R expression enhanced the aggressiveness of tumor cells by potentiating invasion and angiogenesis, leading to poor survival. Collectively, our findings highlight a novel function for Sig1R in mediating cross-talk between cancer cells and their microenvironment, thus driving oncogenesis by shaping cellular electrical activity in response to extracellular signals. Given the involvement of ion channels in promoting several hallmarks of cancer, our study also offers a potential strategy to therapeutically target ion channel function through Sig1R inhibition. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26645564     DOI: 10.1158/0008-5472.CAN-15-1465

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  The multifaceted role of TMEM16A in cancer.

Authors:  David Crottès; Lily Yeh Jan
Journal:  Cell Calcium       Date:  2019-06-14       Impact factor: 6.817

2.  The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasis.

Authors:  M Gueguinou; D Crottès; A Chantôme; R Rapetti-Mauss; M Potier-Cartereau; L Clarysse; A Girault; Y Fourbon; P Jézéquel; C Guérin-Charbonnel; G Fromont; P Martin; B Pellissier; R Schiappa; E Chamorey; O Mignen; A Uguen; F Borgese; C Vandier; O Soriani
Journal:  Oncogene       Date:  2017-01-23       Impact factor: 9.867

3.  Potassium and Calcium Channel Complexes as Novel Targets for Cancer Research.

Authors:  Marie Potier-Cartereau; William Raoul; Gunther Weber; Karine Mahéo; Raphael Rapetti-Mauss; Maxime Gueguinou; Paul Buscaglia; Caroline Goupille; Nelig Le Goux; Souleymane Abdoul-Azize; Thierry Lecomte; Gaëlle Fromont; Aurélie Chantome; Olivier Mignen; Olivier Soriani; Christophe Vandier
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

4.  Development of tumor-targeting aza-vesamicol derivatives with high affinity for sigma receptors for cancer theranostics.

Authors:  Kenji Mishiro; Mengfei Wang; Saki Hirata; Takeshi Fuchigami; Kazuhiro Shiba; Seigo Kinuya; Kazuma Ogawa
Journal:  RSC Med Chem       Date:  2022-06-30

Review 5.  Sigmar1's Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology.

Authors:  Richa Aishwarya; Chowdhury S Abdullah; Mahboob Morshed; Naznin Sultana Remex; Md Shenuarin Bhuiyan
Journal:  Front Physiol       Date:  2021-07-07       Impact factor: 4.566

6.  Ion channels expression and function are strongly modified in solid tumors and vascular malformations.

Authors:  Antonella Biasiotta; Daniela D'Arcangelo; Francesca Passarelli; Ezio Maria Nicodemi; Antonio Facchiano
Journal:  J Transl Med       Date:  2016-10-04       Impact factor: 5.531

Review 7.  Ion channels as therapeutic antibody targets.

Authors:  Catherine J Hutchings; Paul Colussi; Theodore G Clark
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

Review 8.  Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.

Authors:  Seiji Okada; Kulthida Vaeteewoottacharn; Ryusho Kariya
Journal:  Cells       Date:  2019-08-13       Impact factor: 6.600

Review 9.  Small-Molecule Modulators of Sigma1 and Sigma2/TMEM97 in the Context of Cancer: Foundational Concepts and Emerging Themes.

Authors:  Halley M Oyer; Christina M Sanders; Felix J Kim
Journal:  Front Pharmacol       Date:  2019-10-21       Impact factor: 5.810

Review 10.  Sigma Receptors as Endoplasmic Reticulum Stress "Gatekeepers" and their Modulators as Emerging New Weapons in the Fight Against Cancer.

Authors:  Anna Tesei; Michela Cortesi; Alice Zamagni; Chiara Arienti; Sara Pignatta; Michele Zanoni; Mayra Paolillo; Daniela Curti; Marta Rui; Daniela Rossi; Simona Collina
Journal:  Front Pharmacol       Date:  2018-07-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.